EcoDrugPlus

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSFCAG00000024786
Gene Symbol: CYSLTR1
5 Cross references
181 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSFCAG00000037739
Gene Symbol: CDA
5 Cross references
232 Possible Orthologues:

Cytochrome P450 Family 11 Subfamily B Member 1

Ensembl ID : ENSFCAG00000018677
Gene Symbol: CYP11B1
5 Cross references
45 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSFCAG00000001254
Gene Symbol: CYP17A1
5 Cross references
211 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSFCAG00000023859
Gene Symbol: CYP19A1
5 Cross references
319 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSFCAG00000007248
Gene Symbol: CYP26A1
5 Cross references
208 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 131

Ensembl ID : ENSFCAG00000046713
Gene Symbol: CYP3A131
5 Cross references
698 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 132

Ensembl ID : ENSFCAG00000040455
Gene Symbol: CYP3A132
5 Cross references
698 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSFCAG00000001352
Gene Symbol: CYP46A1
5 Cross references
260 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSFCAG00000007725
Gene Symbol: DGAT1
5 Cross references
262 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSFCAG00000026745
Gene Symbol: DHFR
4 Cross references
352 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSFCAG00000026024
Gene Symbol: DHODH
5 Cross references
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).